Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.
about
Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle AtrophyBerberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesisReduced coupling of oxidative phosphorylation in vivo precedes electron transport chain defects due to mild oxidative stress in mice.Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism.Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.Cardiac ubiquitin ligases: Their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential.Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.CYP2D plays a major role in berberine metabolism in liver of mice and humans.Folic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca2+/calmodulin-activated protein kinase II.Vitamin C administration attenuates overload-induced skeletal muscle hypertrophy in rats.Effect of short-term cold exposure on skeletal muscle protein breakdown in rats.Integrated analysis of lncRNA and mRNA expression in rainbow trout families showing variation in muscle growth and fillet quality traits
P2860
Q28072006-3112DCA5-C6C0-4908-84F4-010C8AB3D9BFQ28477076-5D2279B5-F4F9-498B-9BA4-6CC8E861E72AQ34087645-8ABC2787-2930-4D23-8713-C3226F7FDB59Q35055465-660AE038-CA28-4CAE-94D9-3B09D88EF813Q36087285-1653E572-160D-4C00-8727-998BA90DD9F3Q37249112-DEADCA1B-2081-4797-B2B3-AFCF4C2C17BBQ37734762-91339F47-305E-4313-9A35-CE53D0DCC74DQ37912719-F783C568-4182-4773-9529-A47CE0278E75Q38768934-2D5DC4A0-EC64-4855-8E6D-C205140E5790Q38898242-C4947F08-0B78-4EE2-8107-E5DACCBA0BD1Q39492090-EFA3071F-36C5-4C7D-BC5C-84375FEA1D87Q40993104-C030D2EC-84CB-4E54-8E9D-836563113327Q42814641-A406D45F-71C6-415E-A325-27D8B761EB27Q44820634-4F1C8EB3-332F-4961-BDE2-C57D14387641Q47877149-32B5FC9C-7C68-43D4-88CA-062507115247Q58782957-E2BE1496-DC9C-4998-8BB1-420D53A9A07D
P2860
Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@ast
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@en
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@nl
type
label
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@ast
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@en
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@nl
prefLabel
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@ast
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@en
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@nl
P2093
P2860
P356
P1433
P1476
Atrogin-1 affects muscle prote ...... e antidiabetes drug berberine.
@en
P2093
Huiling Wang
Peirang Cao
Stewart Lecker
Zhaoyong Hu
P2860
P304
P356
10.2337/DB10-0207
P407
P577
2010-06-03T00:00:00Z